Description: This 1978 session focused on regulatory considerations in Group Health Insurance focused on the following questions: 1. What is the impact of National Health Insurance and Federal Hospital Cost Control? 2. What is the impact of non-discrimination legislation and regulation? 3. What is the impact of recent OASDI financing changes and changes in mandatory retirement age? 4. What is the future of multi-employer trusts and self-insurance?

Description: Panelists from U.S. and Canada describe their GAAP experience and address the theoretical and practical issues faced by companies moving from a mutual company to a stock company environment. From a session at the Spring regional meeting of the Society of Actuaries held in Atlanta, Georgia, May 24-25, 1999

Description: The panelists at this session of the SOA 2003 Washington, DC Spring Meeting discuss recent GAAP activities including new Standards of Practice for new nontraditional products and internal replacements. Developments at the FASB and SEC are also discussed.

Description: This session at the SOA 1990 Annual Meeting looks at global investing. Areas discussed include rationale for investing globally, fixed income opportunities, a model for active global investing, and other issues.

Description: Experience study covering over 80 continuing care retirement communities, CCRCs, in California including 17 life care communities, offering retirees residential living and services of health care and personal care. Life expectancy experience of residents of CCRCs is developed in support of the California statutory reserve requirements for CCRCs.

Description: Learn about key actuarial and analytic tools and methodologies used by commercial health insurance to identify and quantify drivers of healthcare cost and utilization (including wasteful and low-value ones) and risks. Use case scenarios in which these tools and methodologies apply, such as underwriting, reinsurance, medical management for population health and chronic diseases, managed care contracting, insurance market reform, provider payment reform, etc., will also be covered. Experience from the U.S., China and other parts of the world will be shared.

Description: The purpose of this paper is not to present a revolutionary new concept, instead, it is to reexamine a familiar concept in the light of new market circumstances and, to consider the consequences to the life insurance industry if the concept were adopted.

Description: This paper outlines the limitations inherent in current actuarial pricing techniques and describes a product development process that can produce optimal decisions in competitive environments. From Product Development Section Monograph, M-AS99-3.

Description: The InsurTech market in China is divided into three categories, including online sales of traditional products through internet channels, product upgrades driven by technology, or the creation of more targeted products, and the innovation of eco-system-oriented products, or insurance service by data analysis. The market is expected to reach 1.4 trillion RMB in total.As the digital revolution goes deeper, new technologies have infiltrated into all business models in insurance companies and have promoted the generation and development of the InsurTech market. Digital technologies have been widely used by traditional insurance companies to optimize the procedures and products of the current value chain, bringing a virtuous cycle between InsurTech and the online eco-system. As a result, these traditional insurance companies can expand their business from insurance only to personal finance and other extended services, building a comprehensive solution for the eco-system. Technology is the cornerstone for the business development and innovation of insurance.

Description: Managed strategies as underlying investments in VA/FIA products have seen spectacular growth since the financial crisis. The speakers of these sessions will share their views on the development of this market and what is expected to unfold over the next 12 months in regard to the next generation of products and fund-based strategies.